About Fresenius Medical Care Donora
Address: 470 Galiffa Drive, Donora, Washington County, PA, 15033Phone Number: (724) 379-7650
Certification Date: May 12, 1999
Type and Organization: Profit, Fresenius Medical Care
Number of Dialysis Stations: 13
Fresenius Medical Care Donora Location on Map
Service Offers and Quality Reviews
- In-Center Hemodialysis (YES)
- In-Center Peritoneal Dialysis (YES)
- Home Hemodialysis Training (YES)
- SHR: Upper Confidence Limit (95%): 2.27
- SMR: Upper Confidence Limit (95%): 1.44
- SHR: Lower Confidence Limit (5%): 0.82
- SMR: Lower Confidence Limit (5%): 0.83
- Number of patients included in hospitalization summary: 50
- Number of patients included in survival summary: 265
- Standardized hospitalization ratio: 1.36
- Standardized mortality ratio: 1.1
- Percentage of Medicare patients with Hgb< 10 g/dL: 0.03
- Percentage of Medicare patients with Hgb>12 g/dL: 0
- Number of dialysis patients with Hgb data: 27
- Percentage of HD patients with URR>=65%: 1
- Percent of Adult HD patients with Kt/V >= 1.2: 0.95
- Percentage of Adult PD PTS with Kt/V >= 1.7: n/a
- Number of HD patients with URR data: 27
- Number of Adult HD patients with Kt/V data: 35
- Number of Adult HD patient-months with Kt/V data: 293
- Number of Adult PD patients with Kt/V data: 1
- Number of Adult PD patient-months with Kt/V data: 3
- Number of Pediatric HD patients with Kt/V data: 0
- Number of Pediatric HD patient-months with Kt/V data: 0
- Percentage of patients with arteriovenous fistulae in place: 0.76
- Percentage of patients with vascular catheter in use for 90 days or longer: 0.05
- Number of Adult patients included in arterial venous fistula and catheter summaries: 37
- Number of Adult patient-months included in arterial venous fistula and catheter summaries: 310
(Claims Date: 07/01/2011-06/30/2012; SMR Date: 01/01/2008-12/31/2011; SHR Date: 01/01/2011-12/31/2011)
n/a = Data note available or the number of patients is too small to report, please contacts the dialysis facility to discuss this quality measure.
No comments:
Post a Comment